Published in Clin Chem Lab Med on January 01, 2004
The Challenge of Growth Hormone Deficiency Diagnosis and Treatment during the Transition from Puberty into Adulthood. Front Endocrinol (Lausanne) (2013) 0.91
Mental health in the aged: prevalence, covariates and related neuroendocrine, cardiovascular and inflammatory factors of successful aging. BMC Med Res Methodol (2010) 0.88
Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome. Pharmacogenomics J (2013) 0.88
Effect of zinc supplementation on growth hormone-insulin growth factor axis in short Egyptian children with zinc deficiency. Ital J Pediatr (2012) 0.88
Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancer. PLoS One (2012) 0.88
Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems. Bone Marrow Transplant (2014) 0.83
Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly. Eur J Endocrinol (2015) 0.83
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome. Eur J Endocrinol (2013) 0.81
Functional evaluation of the joints in acromegalic patients and associated factors. Clin Rheumatol (2013) 0.81
Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys (2012) 0.80
Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population. Pituitary (2010) 0.80
STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability. Eur J Endocrinol (2015) 0.79
GH deficiency status combined with GH receptor polymorphism affects response to GH in children. Eur J Endocrinol (2015) 0.79
An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol (2013) 0.79
Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage. Eur J Endocrinol (2013) 0.78
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients. Pituitary (2011) 0.78
Insulin-like growth factor 1 gene (CA)n repeats and a variable number of tandem repeats of the insulin gene in Brazilian children born small for gestational age. Clinics (Sao Paulo) (2013) 0.77
In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life. Endocr Connect (2014) 0.77
Measuring growth hormone and insulin-like growth factor-I in infants: what is normal? Pediatr Endocrinol Rev (2013) 0.76
Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation. PLoS One (2015) 0.76
The trajectory of IGF-1 across age and duration of type 1 diabetes. Diabetes Metab Res Rev (2014) 0.76
Growth hormone and disease severity in early stage of multiple sclerosis. Mult Scler Int (2013) 0.75
Comparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study. Ther Adv Endocrinol Metab (2013) 0.75
Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age. Adv Ther (2016) 0.75
Two Patients with Severe Short Stature due to a FBN1 Mutation (p.Ala1728Val) with a Mild Form of Acromicric Dysplasia. Horm Res Paediatr (2016) 0.75
Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis. Parasit Vectors (2016) 0.75
Evaluation of asymmetric dimethylarginine (ADMA) levels in children with growth hormone deficiency. J Clin Res Pediatr Endocrinol (2014) 0.75
Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device. J Endocrinol Invest (2016) 0.75
Growth hormone deficiency in a patient with becker muscular dystrophy: a pediatric case report. Case Rep Endocrinol (2013) 0.75
Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height. PLoS One (2017) 0.75
Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children. Horm Res Paediatr (2017) 0.75
Relationship between IGF-I Concentration and Metabolic Profile in Children with Growth Hormone Deficiency: The Influence of Children's Nutritional State as well as the Ghrelin, Leptin, Adiponectin, and Resistin Serum Concentrations. Int J Endocrinol (2017) 0.75
Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards. Wien Med Wochenschr (2014) 0.75
Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients. Clin Rheumatol (2014) 0.75
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2004) 2.45
Ketoacidosis at onset of type 1 diabetes mellitus in children--frequency and clinical presentation. Pediatr Diabetes (2003) 1.74
Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry. Arthritis Rheum (2004) 1.66
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) (2006) 1.55
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res (2003) 1.47
Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab (2003) 1.41
Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults. Pharmacogenomics (2008) 1.39
Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults. Clin Chem Lab Med (2002) 1.37
Insulin-like growth factor I concentrations in infancy predict differential gains in body length and adiposity: the Cambridge Baby Growth Study. Am J Clin Nutr (2009) 1.33
Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab (2006) 1.14
Clinical application of automated Greulich-Pyle bone age determination in children with short stature. Pediatr Radiol (2009) 1.12
Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab (2005) 1.10
Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes (2005) 1.10
The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration. J Clin Endocrinol Metab (2008) 1.09
Prediction of adult height based on automated determination of bone age. J Clin Endocrinol Metab (2009) 1.09
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab (2004) 1.07
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol (2006) 1.00
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays. J Clin Endocrinol Metab (2008) 0.98
The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH. J Hepatol (2008) 0.97
Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma. Thyroid (2010) 0.97
Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg (2010) 0.97
Diagnostic proceeding in Silver-Russell syndrome. Mol Diagn (2005) 0.96
Association between head circumference and body size. Horm Res Paediatr (2011) 0.96
The use of bone age in clinical practice - part 1. Horm Res Paediatr (2011) 0.96
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm Res Paediatr (2012) 0.94
Biosimilars: controversies as illustrated by rhGH. Curr Med Res Opin (2010) 0.93
Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetes. Diabetes Technol Ther (2006) 0.93
Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population-based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0-20 years. Pediatr Diabetes (2009) 0.92
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. Expert Opin Pharmacother (2007) 0.91
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany. Oncol Res Treat (2014) 0.90
Automation of bone age reading and a new prediction model improve adult height prediction in children with short stature. Horm Res Paediatr (2013) 0.89
Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod (2013) 0.89
Validation of automatic bone age determination in children with congenital adrenal hyperplasia. Pediatr Radiol (2013) 0.89
Incidence of diabetes mellitus among children of Italian migrants substantiates the role of genetic factors in the pathogenesis of type 1 diabetes. Eur J Pediatr (2008) 0.88
Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation. Langenbecks Arch Surg (2010) 0.88
21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab (2005) 0.88
Standardization of the Tanner-Whitehouse bone age method in the context of automated image analysis. Ann Hum Biol (2011) 0.87
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance. Clin Lab (2004) 0.87
Practical management of everolimus-related toxicities in patients with advanced solid tumors. Onkologie (2013) 0.87
Validation of bone age methods by their ability to predict adult height. Horm Res Paediatr (2010) 0.87
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control. Exp Diabetes Res (2012) 0.86
The use of bone age in clinical practice - part 2. Horm Res Paediatr (2011) 0.86
Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J Pediatr Endocrinol Metab (2006) 0.86
Characterization of genomic variants in CSH1 and GH2, two candidate genes for Silver-Russell syndrome in 17q24-q25. Genet Test (2003) 0.85
Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report. Head Neck (2008) 0.85
Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo. FASEB J (2002) 0.85
No evidence for isolated imprinting mutations in the PEG1/MEST locus in Silver-Russell patients. Eur J Med Genet (2008) 0.85
Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Clin Endocrinol (Oxf) (2008) 0.85
Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state. Diabetes Care (2008) 0.84
Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease. J Diabetes Sci Technol (2007) 0.84
Insulin-like growth factors and binding proteins in early milk from mothers of preterm and term infants. Horm Res (2007) 0.84
Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab (2010) 0.84
Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. J Clin Endocrinol Metab (2008) 0.84
Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Growth Horm IGF Res (2008) 0.83
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome. Eur J Intern Med (2011) 0.83
Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr (2010) 0.83
Identification and prevention of genotyping errors caused by G-quadruplex- and i-motif-like sequences. Clin Chem (2009) 0.83
Physicochemical features of ultra-high viscosity alginates. Carbohydr Res (2009) 0.83
Quality of life and occupational disability in endocrine orbitopathy. Dtsch Arztebl Int (2009) 0.82
The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. J Clin Endocrinol Metab (2004) 0.82
Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*). J Clin Endocrinol Metab (2014) 0.82
Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Horm Res (2004) 0.82
Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr (2006) 0.82
Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp. J Diabetes Sci Technol (2007) 0.81
Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children. Clin Endocrinol (Oxf) (2011) 0.81
Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring) (2014) 0.81
Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome. Clin Endocrinol (Oxf) (2007) 0.81
Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod (2005) 0.81
Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome. Appl Health Econ Health Policy (2013) 0.81
Automatic determination of left- and right-hand bone age in the First Zurich Longitudinal Study. Horm Res Paediatr (2010) 0.81
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency. Horm Res (2003) 0.80
Copy number variants in short children born small for gestational age. Horm Res Paediatr (2014) 0.80
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus. J Diabetes Sci Technol (2012) 0.80
Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators? Neuroimmunomodulation (2004) 0.80
Molecular imaging of gastroenteropancreatic neuroendocrine tumors. Gastroenterol Clin North Am (2010) 0.80
Total pubertal growth and markers of puberty onset in adolescents with GHD: comparison between mathematical growth analysis and pubertal staging methods. Horm Res (2005) 0.80
Predicting the response to growth hormone treatment in short children with chronic kidney disease. J Clin Endocrinol Metab (2009) 0.80
A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus. Clin Lab (2008) 0.79
Validation of automatic bone age rating in children with precocious and early puberty. J Pediatr Endocrinol Metab (2011) 0.79
Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. Eur J Endocrinol (2004) 0.79
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin. Eur J Endocrinol (2008) 0.79
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET. Eur J Nucl Med Mol Imaging (2013) 0.79
Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Heart (2007) 0.79
MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. AJNR Am J Neuroradiol (2003) 0.79
MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism. J Pediatr Endocrinol Metab (2007) 0.78
Growth hormone binding protein levels in children are associated with birth weight, postnatal weight gain, and insulin secretion. Metabolism (2007) 0.78
Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR. Clin Lab (2012) 0.78
Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach. Horm Res Paediatr (2013) 0.78
LOT1 (ZAC1/PLAGL1) as member of an imprinted gene network does not harbor Silver-Russell specific variants. J Pediatr Endocrinol Metab (2009) 0.78
Magnetic separation of encapsulated islet cells labeled with superparamagnetic iron oxide nano particles. Xenotransplantation (2013) 0.78
Overexpression of the insulin-like growth factor I receptor in human pheochromocytomas. J Mol Endocrinol (2006) 0.78
Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimens. Clin Lab (2005) 0.78
[The highly gifted persons study by Adele Juda 1927-1955. Pinnacle and end of psychiatric genius research in Germany]. Sudhoffs Arch (2007) 0.77
Laboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammation. J Diabetes Sci Technol (2010) 0.77
Molecular effects of C-Peptide in microvascular blood flow regulation. Rev Diabet Stud (2009) 0.77
The Directions of psychiatric research by Emil Kraepelin. 1887. Hist Psychiatry (2005) 0.77
Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study. J Inherit Metab Dis (2012) 0.77